FDA Adverse Event
Injury
Summary report: N
ENDOTAK RELIANCE
MDR report key: 4140490
·
Received October 3, 2014
Report
- Report Number
- 2124215-2014-17351
- Event Type
- Injury
- Date Received
- October 3, 2014
- Date of Event
- July 16, 2014
- Report Date
- September 16, 2014
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
(B)(4). DETAILED ANALYSIS IS BEING PERFORMED ON THIS LEAD. UPON COMPLETION OF ANALYSIS, THIS REPORT WILL BE UPDATED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT'S (RV) LEAD HAD EXHIBITED INCREASED THRESHOLDS AND INTERMITTENT CAPTURE. THE LEAD WAS REPOSITIONED. AFTER THE REPOSITIONING THERE WERE EPISODES OF NON SUSTAINED OVERSENSING THAT LEAD TO PERIODS OF PACING INHIBITION AND NOISE. THE DEVICE PROGRAMMING WAS CHANGED IN AN EFFORT TO ALLEVIATE. LATER, THE PATIENT WENT TO THE EMERGENCY ROOM DUE TO A SYNCOPAL EVENT. UPON INTERROGATION OF THE DEVICE IT WAS NOTED THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD DISLODGED. THE LEAD WAS THEN EXPLANTED AND REPLACED. TO DATE, NO ADDITIONAL ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 618823 | ENDOTAK RELIANCE | NVY | CPI - DEL CARIBE | 0293 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 81 YR | Hospitalization| L| R | 0293 |